{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:07:17Z","timestamp":1770412037819,"version":"3.49.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.6061\/clinics\/2012(sup01)10","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T17:56:33Z","timestamp":1335290193000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype\u2013phenotype correlation"],"prefix":"10.1016","volume":"67","author":[{"given":"Cornelis J.","family":"Lips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen M.","family":"Dreijerink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo W.","family":"H\u00f6ppener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)10_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/humu.10092","article-title":"Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein","volume":"20","author":"Wautot","year":"2002","journal-title":"Hum Mutat"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)10_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archsurg.137.6.641","article-title":"Genotype-phenotype analysis in multiple endocrine neoplasia type 1","volume":"137","author":"Kouvaraki","year":"2002","journal-title":"Arch Surg"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)10_bib3","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1210\/jcem.87.6.8607","article-title":"Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1","volume":"87","author":"Turner","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)10_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)10_bib5","first-page":"69","article-title":"Clinical characteristics of multiple endocrine neoplasia","volume":"194","author":"Conte-Devolx","year":"2010","journal-title":"Bull Acad Natl Med"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00005792-197503000-00001","article-title":"Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: multiple endocrine neoplasia-type III","volume":"54","author":"Khairi","year":"1975","journal-title":"Medicine"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5311","key":"10.6061\/clinics\/2012(Sup01)10_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)10_bib10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the MEN1 gene. The European consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib11","first-page":"301","article-title":"Differentially expressed genes in Men1 knockout and wild type embryoid bodies for pancreatic islet development","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol Med Report"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)10_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)10_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1073\/pnas.0408836102","article-title":"Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors","volume":"102","author":"Milne","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)10_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0092-8674(03)00430-6","article-title":"Multiple tumor suppressor pathways negatively regulate telomerase","volume":"113","author":"Lin","year":"2003","journal-title":"Cell"},{"issue":"10","key":"10.6061\/clinics\/2012(Sup01)10_bib15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncpendmet0292","article-title":"Mechanism of disease: MEN 1-relation to chromatin modifications and transcription regulation","volume":"2","author":"Dreijerink","year":"2006","journal-title":"Nat Clin Pract Endocr Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0092-8674(00)80967-8","article-title":"Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription","volume":"96","author":"Agarwal","year":"1999","journal-title":"Cell"},{"issue":"13","key":"10.6061\/clinics\/2012(Sup01)10_bib17","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","article-title":"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression","volume":"24","author":"Yokoyama","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"19","key":"10.6061\/clinics\/2012(Sup01)10_bib18","first-page":"6135","article-title":"Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib19","doi-asserted-by":"crossref","first-page":"31742","DOI":"10.1074\/jbc.M111.258186","article-title":"Crystal structure of Menin reveals the binding site for mixed lineage Leukemia (MLL) protein","volume":"9","author":"Murai","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)10_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","article-title":"Menin critically links MLL proteins with LEDGF on cancer-associated target genes","volume":"14","author":"Yokoyama","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1593\/neo.06706","article-title":"Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation","volume":"9","author":"Agarwal","year":"2007","journal-title":"Neoplasia"},{"issue":"36","key":"10.6061\/clinics\/2012(Sup01)10_bib22","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/sj.onc.1204529","article-title":"The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation","volume":"20","author":"Heppner","year":"2001","journal-title":"Oncogene"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1006\/bbrc.2001.5405","article-title":"Menin interacts directly with the homeobox-containing protein Pem","volume":"286","author":"Lemmens","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)10_bib24","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1073\/pnas.061358098","article-title":"Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling","volume":"98","author":"Kaji","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)10_bib25","first-page":"3911","article-title":"Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors","volume":"87","author":"Shattuck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.6061\/clinics\/2012(Sup01)10_bib26","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1158\/1541-7786.MCR-07-2206","article-title":"Menin promotes the Wnt signaling pathway in pancreatic endocrine cells","volume":"6","author":"Chen","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"9","key":"10.6061\/clinics\/2012(Sup01)10_bib27","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-05-4461","article-title":"Menin links estrogen receptor activation to histone H3K4 trimethylation","volume":"66","author":"Dreijerink","year":"2006","journal-title":"Cancer Res"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)10_bib28","doi-asserted-by":"crossref","first-page":"E474","DOI":"10.1152\/ajpendo.00022.2011","volume":"301","author":"Wuescher","year":"2011","journal-title":"Am J Phsyiol Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/MCB.23.2.493-509.2003","article-title":"The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene","volume":"23","author":"Sukhodolets","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"18","key":"10.6061\/clinics\/2012(Sup01)10_bib30","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1158\/0008-5472.CAN-04-0724","article-title":"Functional interaction between tumor suppressor menin and activator of S-phase kinase","volume":"64","author":"Schnepp","year":"2004","journal-title":"Cancer Res"},{"issue":"17","key":"10.6061\/clinics\/2012(Sup01)10_bib31","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1158\/0008-5472.CAN-06-0061","article-title":"Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response","volume":"66","author":"Busygina","year":"2006","journal-title":"Cancer Res"},{"issue":"14","key":"10.6061\/clinics\/2012(Sup01)10_bib32","first-page":"4204","article-title":"Menin associates with FANCD2, a protein involved in repair of DNA damage","volume":"63","author":"Jin","year":"2003","journal-title":"Cancer Res"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/excr.2002.5575","article-title":"Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity","volume":"278","author":"Lopez-Egido","year":"2002","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/0008-5472.CAN-10-3221","article-title":"The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)10_bib35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1006\/bbrc.2001.4723","article-title":"Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23","volume":"282","author":"Ohkura","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)10_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/onc.2008.435","article-title":"Menin interacts with IQGAP1 to enhance intercellular adhesion of beta-cells","volume":"28","author":"Yan","year":"2009","journal-title":"Oncogene"},{"issue":"41","key":"10.6061\/clinics\/2012(Sup01)10_bib37","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1038\/sj.onc.1206658","article-title":"Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain","volume":"22","author":"Obungu","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)10_bib38","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.4158\/EP10291.CR","article-title":"A novel missense mutation in the MEN1 gene in a patient with multiple endocrine neoplasia type 1","volume":"17","author":"Hou","year":"2011","journal-title":"Endocr Pract"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)10_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-07-0195","article-title":"Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation","volume":"157","author":"Vierimaa","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)10_bib40","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1053\/j.gastro.2008.07.031","article-title":"MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells","volume":"135","author":"Bazzi","year":"2008","journal-title":"Gastroenterology"},{"issue":"15","key":"10.6061\/clinics\/2012(Sup01)10_bib41","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1128\/MCB.24.15.6569-6580.2004","article-title":"Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway","volume":"24","author":"Yaguchi","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)10_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<264::AID-HUMU2>3.0.CO;2-V","article-title":"Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1-Burin) in four kindreds from Newfoundland","volume":"11","author":"Olufemi","year":"1998","journal-title":"Hum Mutat"},{"issue":"10","key":"10.6061\/clinics\/2012(Sup01)10_bib43","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/BF03343931","article-title":"Multiple endocrine neoplasia type 1Burin from Mauritius: a novel MEN1 mutation","volume":"24","author":"Kong","year":"2001","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)10_bib44","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1210\/jc.2003-031511","article-title":"Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma","volume":"89","author":"Hao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib45","first-page":"8","article-title":"The MEN1 gene and pituitary tumours","volume":"71(Suppl. 2)","author":"Agarwal","year":"2009","journal-title":"Horm Res"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)10_bib46","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1086\/302097","article-title":"A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors","volume":"63","author":"Teh","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1530\/eje.0.1420138","article-title":"A novel mutation of the MEN1 gene in a Japanese kindred with familial isolated primary hyperparathyroidism","volume":"142","author":"Honda","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)10_bib48","first-page":"165","article-title":"Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree","volume":"85","author":"Kassem","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)10_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/eje.0.1450155","article-title":"Familial isolated primary hyperparathyroidism\u2013a multiple endocrine neoplasia type 1 variant","volume":"145","author":"Miedlich","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)10_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1530\/eje.0.1470313","article-title":"Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism","volume":"147","author":"Villablanca","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds","volume":"81","author":"Simonds","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2265.2003.01765.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism","volume":"58","author":"Pannett","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ncpendmet0718","article-title":"Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene","volume":"4","author":"Hannan","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1507\/endocrj.45.753","article-title":"A family of MEN1 with a novel germline missense mutation and benign polymorphisms","volume":"45","author":"Miyauchi","year":"1998","journal-title":"Endocr J"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2169\/internalmedicine.42.1112","article-title":"A novel missense mutation of the MEN1 gene in a multiple endocrine neoplasia type 1 patient associated with carcinoid syndrome","volume":"42","author":"Ukita","year":"2003","journal-title":"Intern Med"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2007-970160","article-title":"Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1","volume":"115","author":"Schaaf","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/jc.2003-032101","article-title":"Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism","volume":"89","author":"Carrasco","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1530\/eje.1.02022","article-title":"Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease","volume":"153","author":"Dreijerink","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0029-1216358","article-title":"An Intronic mutation is associated with prolactinoma in a young boy, decreased penetrance in his large family, and variable effects on MEN1 mRNA and protein","volume":"41","author":"Drori-Herishanu","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2011.04134.x","article-title":"A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype","author":"Raef","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10689-010-9412-z","article-title":"A new frameshift MEN1 gene mutation associated with familial malignant insulinomas","volume":"10","author":"Hasani-Ranjbar","year":"2011","journal-title":"Fam Cancer"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib62","first-page":"80","article-title":"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib63","article-title":"Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers","author":"van Wijk","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1530\/EJE-08-0153","article-title":"MEN1 type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile","volume":"159","author":"Louren\u00e7o","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis","volume":"92","author":"Pittas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2337\/dc09-2321","article-title":"Association of vitamin D with insulin resistance an beta cell dysfunction in subjects at risk for diabetes","volume":"33","author":"Kayaniyil","year":"2010","journal-title":"Diabetes Care"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis.A 734-case cohort study from the GTE (Groupe d'etude des Tumeurs Endocrines)","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib68","first-page":"47","article-title":"Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. Hum Mol Genet. 16, spec No 1R73-9. (2007)","volume":"20","author":"Karhu","year":"2002","journal-title":"Hum Mutat"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jc.2008-1003","article-title":"Large genomic deletions in AIP in pituitary adenoma predisposition","volume":"93","author":"Georgitsi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/bies.20606","article-title":"The evolving concept of tumor microenvironments","volume":"29","author":"Laconi","year":"2007","journal-title":"Bioessays"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2009.08.020","article-title":"Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas","volume":"313","author":"Dreijerink","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/0008-5472.CAN-07-5754","article-title":"Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development","volume":"68","author":"van Veelen","year":"2008","journal-title":"Cancer Res"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijc.23977","article-title":"P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development","volume":"124","author":"Van Veelen","year":"2009","journal-title":"Int J Cancer"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib74","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib75","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2265.2008.03363.x","article-title":"Germline mutations in the CDKN1B gene encoding p27 Kip1 are a rare cause of multiple endocrine neoplasia type 1","volume":"70","author":"Owens","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2265.2008.03379.x","article-title":"Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations","volume":"70","author":"Igreja","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib77","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/MCB.01764-06","article-title":"p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors","volume":"27","author":"Bai","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib78","first-page":"20","article-title":"The MENX syndrome and p27: relationships with multiple endocrine neoplasia","volume":"182","author":"Molatore","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000320366","article-title":"p27kip1: a new multiple endocrine neoplasia gene","volume":"93","author":"Marinoni","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib80","first-page":"86","article-title":"The role of menin in parathyroid tumorigenesis","volume":"668","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.beem.2009.05.004","article-title":"The pathophysiology of pituitary adenomas","volume":"23","author":"Dworakowska","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/me.2005-0253","article-title":"The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor","volume":"20","author":"Seoane","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/me.2003-0470","article-title":"Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin","volume":"18","author":"Lacerte","year":"2004","journal-title":"Mol Endocr"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib84","first-page":"78","article-title":"Activin, TGF-beta and menin in pituitary tumorigenesis","volume":"668","author":"Lebrun","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib86","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1507\/endocrj.K10E-158","article-title":"Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor","volume":"58","author":"Ishida","year":"2011","journal-title":"Endocr J"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib87","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"Cully","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1245\/s10434-009-0591-5","article-title":"Inhibition of phosphatidylinositol 3-kinase\/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors","volume":"16","author":"Pitt","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.onc.1203005","article-title":"Stable overexpression of MEN1 suppresses tumorgenicity of RAS","volume":"18","author":"Kim","year":"1999","journal-title":"Oncogene"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/er.2003-0037","article-title":"Hereditary hormone excess: genes, molecular pathways, and syndromes","volume":"26","author":"Marx","year":"2005","journal-title":"Endocr Rev"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib91","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"10.6061\/clinics\/2012(Sup01)10_bib92","first-page":"5","article-title":"Annual Oration before the Medical Society of London by Sir Archibald Garrod","volume":"26","year":"1928","journal-title":"Br Med J"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222023961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222023961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-s1\/cln-67-s1-49.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:12:30Z","timestamp":1761721950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222023961"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012001300010&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3328827\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":92,"alternative-id":["S1807593222023961"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(sup01)10","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype\u2013phenotype correlation","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(Sup01)10","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}